It is also worth noting that previous protein-based signaling studies of breast cancer cell lines and tumors with and without PIK3CA mutations found that PIK3CA mutations were associated with lower and/or inconsistent PI3K pathway activation [33,36,38]. This evidence concerns the gene PIK3CA and breast cancer.